Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Annals of Surgery|July 7, 2022
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesTimothy E Newhook, Michael J Overman, Yun Shin Chun, et al.
Oncotarget|May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget|September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Cancer Research Communications|November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancerVan K Morris, Michael J Overman, Michael Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2024
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1DJonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, et al.
JAMA Network Open|October 14, 2022
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal CancerJennifer S Davis, Janelle C Chavez, Melissa Kok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid TumorsKaysia Ludford, Won Jin Ho, Jane V Thomas, et al.
Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.
Pageof 22